Vimarsana
Biggest News Aggregation in the World

Christopher Henney News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Christopher Henney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Christopher Henney Today - Breaking & Trending Today

Cyclacel Pharmaceuticals Announces That Kenneth M. - Vimarsana News

Cyclacel Pharmaceuticals Announces That Kenneth M.

BERKELEY HEIGHTS, N.J., June 22, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a...

Agribusiness Conference drives Agribusinesses to new heights - Vimarsana News

Agribusiness Conference drives Agribusinesses to new heights

COLUMBUS — More than 300 Ohio AgriBusiness Association (OABA) members and industry professionals were on hand to engage in collaborative learning and

OABA Conference drives agribusinesses to new heights - Vimarsana News

OABA Conference drives agribusinesses to new heights

More than 300 Ohio AgriBusiness Association (OABA) members and industry professionals were on hand to engage in collaborative learning and networking at the org

Source: ocj.com
Cyclacel Pharmaceuticals Announces That Brian Schwartz, M.D. Was Elected to Its Board of DirectorsFormer CMO & Head of R&D of ArQule joins the Board - Vimarsana News

Cyclacel Pharmaceuticals Announces That Brian Schwartz, M.D. Was Elected to Its Board of DirectorsFormer CMO & Head of R&D of ArQule joins the Board

Published: Dec 21, 2020 BERKELEY HEIGHTS, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) --Cyclacel Pharmaceuticals, Inc., (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, today announced the election of Brian Schwartz, M.D., to its Board of Directors. "We are very pleased to have Brian join the Board of Directors of Cyclacel. His extensive clinical and product development experience further adds to the strength of our Board and will support management’s efforts to build shareholder value," said ...